Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17beta-estradiol (1.5mg)

Trial Profile

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17beta-estradiol (1.5mg)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2016

At a glance

  • Drugs Estradiol/nomegestrol (Primary) ; Oral contraceptives
  • Indications Pregnancy
  • Focus Adverse reactions
  • Acronyms INAS-CELINA; PRO-E2
  • Most Recent Events

    • 02 Nov 2016 Planned End Date changed from 1 Oct 2017 to 1 Jun 2020.
    • 02 Nov 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Feb 2020.
    • 30 Jul 2014 Planned number of patients changed from 61500 to 101000, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top